NVCT Annual CFF
$15.09 M
-$12.72 M-45.75%
31 December 2023
Summary:
As of January 23, 2025, NVCT annual cash flow from financing activities is $15.09 million, with the most recent change of -$12.72 million (-45.75%) on December 31, 2023. NVCT annual CFF is now -45.75% below its all-time high of $27.81 million, reached on December 31, 2022.NVCT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCT Quarterly CFF
$1.46 M
-$215.00 K-12.86%
30 September 2024
Summary:
As of January 23, 2025, NVCT quarterly cash flow from financing activities is $1.46 million, with the most recent change of -$215.00 thousand (-12.86%) on September 30, 2024. Over the past year, it has increased by +$754.00 thousand (+107.25%). NVCT quarterly CFF is now -89.95% below its all-time high of $14.49 million, reached on September 30, 2022.NVCT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCT TTM CFF
$8.74 M
+$754.00 K+9.44%
30 September 2024
Summary:
As of January 23, 2025, NVCT TTM cash flow from financing activities is $8.74 million, with the most recent change of +$754.00 thousand (+9.44%) on September 30, 2024. Over the past year, it has dropped by -$5.30 million (-37.73%). NVCT TTM CFF is now -70.14% below its all-time high of $29.27 million, reached on March 31, 2022.NVCT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCT Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -45.8% | +107.3% | -37.7% |
| 3 y3 years | - | +107.3% | -37.7% |
| 5 y5 years | - | +107.3% | -37.7% |
NVCT Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -45.8% | at low | -90.0% | +352.1% | -70.1% | +9.4% |
| 5 y | 5-year | -45.8% | at low | -90.0% | +352.1% | -70.1% | |
| alltime | all time | -45.8% | at low | -90.0% | +352.1% | -70.1% |
Nuvectis Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.46 M(-12.9%) | $8.74 M(+9.4%) |
| June 2024 | - | $1.67 M(-64.4%) | $7.99 M(-59.1%) |
| Mar 2024 | - | $4.70 M(+412.1%) | $19.53 M(+29.5%) |
| Dec 2023 | $15.09 M(-45.7%) | $917.00 K(+30.4%) | $15.09 M(+7.5%) |
| Sept 2023 | - | $703.00 K(-94.7%) | $14.04 M(-49.6%) |
| June 2023 | - | $13.21 M(+5144.0%) | $27.83 M(+98.3%) |
| Mar 2023 | - | $252.00 K(-292.4%) | $14.04 M(-49.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $27.81 M(+82.4%) | -$131.00 K(-100.9%) | $27.81 M(-0.5%) |
| Sept 2022 | - | $14.49 M(-2607.3%) | $27.94 M(+59.9%) |
| June 2022 | - | -$578.00 K(-104.1%) | $17.47 M(-40.3%) |
| Mar 2022 | - | $14.03 M(>+9900.0%) | $29.27 M(+92.0%) |
| Dec 2021 | $15.25 M | $0.00(-100.0%) | $15.25 M(0.0%) |
| Sept 2021 | - | $4.02 M(-64.2%) | $15.25 M(+35.8%) |
| June 2021 | - | $11.22 M(>+9900.0%) | $11.22 M(>+9900.0%) |
| Mar 2021 | - | $0.00 | $0.00 |
FAQ
- What is Nuvectis Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for Nuvectis Pharma?
- What is Nuvectis Pharma annual CFF year-on-year change?
- What is Nuvectis Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly CFF year-on-year change?
- What is Nuvectis Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Nuvectis Pharma?
- What is Nuvectis Pharma TTM CFF year-on-year change?
What is Nuvectis Pharma annual cash flow from financing activities?
The current annual CFF of NVCT is $15.09 M
What is the all time high annual CFF for Nuvectis Pharma?
Nuvectis Pharma all-time high annual cash flow from financing activities is $27.81 M
What is Nuvectis Pharma annual CFF year-on-year change?
Over the past year, NVCT annual cash flow from financing activities has changed by -$12.72 M (-45.75%)
What is Nuvectis Pharma quarterly cash flow from financing activities?
The current quarterly CFF of NVCT is $1.46 M
What is the all time high quarterly CFF for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly cash flow from financing activities is $14.49 M
What is Nuvectis Pharma quarterly CFF year-on-year change?
Over the past year, NVCT quarterly cash flow from financing activities has changed by +$754.00 K (+107.25%)
What is Nuvectis Pharma TTM cash flow from financing activities?
The current TTM CFF of NVCT is $8.74 M
What is the all time high TTM CFF for Nuvectis Pharma?
Nuvectis Pharma all-time high TTM cash flow from financing activities is $29.27 M
What is Nuvectis Pharma TTM CFF year-on-year change?
Over the past year, NVCT TTM cash flow from financing activities has changed by -$5.30 M (-37.73%)